101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Appoints Thomas R. Staab, II as Chief Financial Officer
Annual Report to Security Holders
Financial Results, Press Release
Dr. Stuart Rich's Employment Agreement Amended; Salary Adjusted
Announces Result of Prespecifed Blinded Sample Size Assessment
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report